| drug metabolic process | GO:0017144 | 4 | 0.807 | |
| inflammatory response | GO:0006954 | 244 | 0.792 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.781 | |
| angiogenesis | GO:0001525 | 201 | 0.687 | |
| drug catabolic process | GO:0042737 | 2 | 0.616 | |
| response to oxidative stress | GO:0006979 | 123 | 0.569 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.474 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.458 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.452 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.447 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.402 | |
| cell chemotaxis | GO:0060326 | 81 | 0.389 | |
| regulation of cell activation | GO:0050865 | 289 | 0.379 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.353 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.349 | |
| regulation of defense response | GO:0031347 | 233 | 0.342 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.342 | |
| response to hypoxia | GO:0001666 | 58 | 0.330 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.302 | |
| thymocyte migration | GO:0072679 | 2 | 0.293 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.292 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.292 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.283 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.281 | |
| cytokine production | GO:0001816 | 319 | 0.276 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.264 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.261 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.248 | |
| response to peptide hormone | GO:0043434 | 127 | 0.222 | |
| leukocyte migration | GO:0050900 | 124 | 0.205 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.201 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.196 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.194 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.186 | |
| response to oxygen levels | GO:0070482 | 62 | 0.183 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.182 | |
| amine metabolic process | GO:0009308 | 45 | 0.181 | |
| oxidation reduction process | GO:0055114 | 342 | 0.180 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.179 | |
| response to peptide | GO:1901652 | 136 | 0.177 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.174 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.169 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.169 | |
| granulocyte migration | GO:0097530 | 43 | 0.168 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.164 | |
| t cell activation | GO:0042110 | 289 | 0.164 | |
| neutrophil migration | GO:1990266 | 37 | 0.159 | |
| interleukin 12 secretion | GO:0072610 | 3 | 0.158 | |
| antibacterial peptide biosynthetic process | GO:0002780 | 2 | 0.156 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.156 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.155 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.155 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.154 | |
| positive regulation of neutrophil chemotaxis | GO:0090023 | 12 | 0.154 | |
| defense response to bacterium | GO:0042742 | 119 | 0.153 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.150 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.150 | |
| neutrophil chemotaxis | GO:0030593 | 36 | 0.148 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.148 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.147 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.140 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.140 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.140 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.137 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.137 | |
| protein maturation | GO:0051604 | 176 | 0.136 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.134 | |
| regulation of cell motility | GO:2000145 | 236 | 0.134 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.133 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.133 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.131 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.131 | |
| fat cell differentiation | GO:0045444 | 160 | 0.131 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.129 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.128 | |
| response to insulin | GO:0032868 | 100 | 0.123 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.123 | |
| immune effector process | GO:0002252 | 321 | 0.123 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.122 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.122 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.119 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.117 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.116 | |
| protein processing | GO:0016485 | 163 | 0.116 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.115 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.115 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.114 | |
| keratinocyte migration | GO:0051546 | 3 | 0.112 | |
| response to acid chemical | GO:0001101 | 111 | 0.112 | Mouse |
| wound healing | GO:0042060 | 157 | 0.108 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.108 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.108 | |
| chemotaxis | GO:0006935 | 247 | 0.106 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.106 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.105 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.105 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.105 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.105 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.104 | Rat |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.102 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.101 | |
| positive regulation of granulocyte chemotaxis | GO:0071624 | 12 | 0.101 | |
| cytokine secretion | GO:0050663 | 72 | 0.100 | |
| positive regulation of t cell differentiation | GO:0045582 | 52 | 0.099 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.098 | |
| inflammatory response to wounding | GO:0090594 | 4 | 0.098 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.098 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.098 | |
| t cell proliferation | GO:0042098 | 120 | 0.097 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.096 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.094 | |
| mapk cascade | GO:0000165 | 281 | 0.093 | |
| regulation of natural killer cell chemotaxis | GO:2000501 | 1 | 0.093 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.092 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.089 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.088 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.087 | |
| regulation of secretion | GO:0051046 | 274 | 0.086 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.086 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.086 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.085 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.085 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.084 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.084 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.083 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.083 | |
| muscle system process | GO:0003012 | 141 | 0.083 | |
| regulation of protein processing | GO:0070613 | 96 | 0.082 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.082 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.082 | |
| regulation of chemokine production | GO:0032642 | 30 | 0.082 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.082 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.082 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.081 | |
| response to corticosteroid | GO:0031960 | 20 | 0.081 | |
| sterol metabolic process | GO:0016125 | 58 | 0.080 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.080 | |
| adaptive immune response | GO:0002250 | 155 | 0.079 | |
| positive regulation of type 2 immune response | GO:0002830 | 9 | 0.078 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.078 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.078 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.077 | |
| positive regulation of monocyte chemotaxis | GO:0090026 | 2 | 0.077 | |
| cell cell recognition | GO:0009988 | 44 | 0.077 | |
| protein glycosylation | GO:0006486 | 55 | 0.076 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.075 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.075 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.074 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.073 | |
| cell death in response to oxidative stress | GO:0036473 | 24 | 0.073 | |
| positive regulation of macrophage chemotaxis | GO:0010759 | 5 | 0.072 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.072 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.071 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.070 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.069 | |
| wound healing involved in inflammatory response | GO:0002246 | 4 | 0.068 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.068 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.068 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.068 | |
| cation transport | GO:0006812 | 399 | 0.068 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.067 | |
| sensory perception | GO:0007600 | 245 | 0.067 | |
| male gamete generation | GO:0048232 | 285 | 0.066 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.066 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.066 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.066 | |
| regulation of granulocyte chemotaxis | GO:0071622 | 17 | 0.066 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.066 | |
| regulation of b cell mediated immunity | GO:0002712 | 37 | 0.066 | |
| response to interleukin 1 | GO:0070555 | 11 | 0.066 | |
| cartilage development | GO:0051216 | 140 | 0.065 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.065 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.064 | |
| innate immune response | GO:0045087 | 157 | 0.064 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.064 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.063 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.063 | |
| defense response to other organism | GO:0098542 | 197 | 0.063 | |
| regulation of cell migration | GO:0030334 | 219 | 0.063 | |
| response to growth factor | GO:0070848 | 198 | 0.063 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.063 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.062 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.062 | |
| positive regulation of b cell chemotaxis | GO:2000538 | 2 | 0.062 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.062 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.062 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.061 | |
| regulation of thymocyte migration | GO:2000410 | 2 | 0.060 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.060 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.060 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.060 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.060 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.060 | |
| positive regulation of alpha beta t cell activation | GO:0046635 | 39 | 0.059 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.059 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.059 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.059 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.059 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.058 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.058 | |
| regulation of t helper 1 type immune response | GO:0002825 | 17 | 0.058 | |
| cytokine production involved in inflammatory response | GO:0002534 | 9 | 0.058 | |
| granulocyte chemotaxis | GO:0071621 | 39 | 0.058 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.056 | |
| circulatory system process | GO:0003013 | 197 | 0.055 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.055 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.055 | |
| positive regulation of renal sodium excretion | GO:0035815 | 2 | 0.054 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.054 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.054 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.054 | |
| response to drug | GO:0042493 | 75 | 0.053 | Mouse |
| connective tissue development | GO:0061448 | 179 | 0.053 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.053 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.053 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.052 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.052 | |
| peptide secretion | GO:0002790 | 114 | 0.052 | |
| ureteric bud development | GO:0001657 | 94 | 0.052 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.052 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.052 | |
| regulation of system process | GO:0044057 | 200 | 0.051 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.051 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.051 | |
| multicellular organism growth | GO:0035264 | 161 | 0.050 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.050 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.050 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.050 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.050 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.050 | |
| positive regulation of t helper 1 cell differentiation | GO:0045627 | 4 | 0.050 | |
| regulation of neuron death | GO:1901214 | 134 | 0.050 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.050 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.049 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.049 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.048 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.048 | |
| type 2 immune response | GO:0042092 | 23 | 0.048 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.048 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.048 | |
| myotube differentiation | GO:0014902 | 105 | 0.048 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.047 | |
| organ growth | GO:0035265 | 117 | 0.047 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.046 | |
| positive regulation of alpha beta t cell differentiation | GO:0046638 | 28 | 0.046 | |
| phasic smooth muscle contraction | GO:0014821 | 8 | 0.046 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.046 | |
| response to purine containing compound | GO:0014074 | 28 | 0.046 | |
| cell adhesion | GO:0007155 | 329 | 0.046 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.045 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.045 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.045 | |
| positive regulation of natural killer cell chemotaxis | GO:2000503 | 1 | 0.044 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.044 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.044 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.044 | |
| stem cell differentiation | GO:0048863 | 268 | 0.044 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.044 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.043 | |
| regulation of neutrophil chemotaxis | GO:0090022 | 14 | 0.043 | |
| hormone secretion | GO:0046879 | 128 | 0.043 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.043 | |
| rhythmic process | GO:0048511 | 174 | 0.043 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.043 | |
| mesonephros development | GO:0001823 | 97 | 0.043 | |
| respiratory tube development | GO:0030323 | 167 | 0.042 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.042 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.042 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.042 | |
| eosinophil migration | GO:0072677 | 3 | 0.042 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.042 | |
| basement membrane organization | GO:0071711 | 8 | 0.042 | |
| positive regulation of t helper 1 cell cytokine production | GO:2000556 | 1 | 0.042 | |
| extracellular structure organization | GO:0043062 | 148 | 0.041 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.041 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.041 | |
| response to organophosphorus | GO:0046683 | 22 | 0.041 | |
| endochondral bone growth | GO:0003416 | 19 | 0.041 | |
| t cell differentiation | GO:0030217 | 174 | 0.041 | |
| phagocytosis | GO:0006909 | 66 | 0.041 | |
| regulation of type 2 immune response | GO:0002828 | 18 | 0.041 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.040 | |
| spermatogenesis | GO:0007283 | 284 | 0.040 | |
| astrocyte cell migration | GO:0043615 | 3 | 0.040 | |
| activation of nf kappab inducing kinase activity | GO:0007250 | 4 | 0.040 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.040 | |
| regulation of immunoglobulin mediated immune response | GO:0002889 | 37 | 0.040 | |
| response to tumor necrosis factor | GO:0034612 | 26 | 0.040 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.039 | |
| positive regulation of macrophage activation | GO:0043032 | 10 | 0.039 | |
| response to inorganic substance | GO:0010035 | 96 | 0.039 | |
| icosanoid biosynthetic process | GO:0046456 | 15 | 0.039 | |
| response to heat | GO:0009408 | 27 | 0.039 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.039 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.039 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.039 | |
| regulation of t helper 2 cell cytokine production | GO:2000551 | 3 | 0.039 | |
| maintenance of location | GO:0051235 | 89 | 0.038 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.038 | |
| cellular homeostasis | GO:0019725 | 240 | 0.038 | |
| blood circulation | GO:0008015 | 195 | 0.038 | |
| mature natural killer cell chemotaxis | GO:0035782 | 1 | 0.038 | |
| placenta development | GO:0001890 | 140 | 0.038 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.038 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.038 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.038 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.038 | |
| regulation of eosinophil migration | GO:2000416 | 2 | 0.038 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.038 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.038 | |
| negative regulation of macrophage apoptotic process | GO:2000110 | 3 | 0.038 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.038 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.037 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.037 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.037 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.037 | |
| b cell activation | GO:0042113 | 161 | 0.037 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.037 | |
| protein catabolic process | GO:0030163 | 221 | 0.037 | |
| membrane depolarization | GO:0051899 | 64 | 0.037 | |
| regulation of cd4 positive alpha beta t cell activation | GO:2000514 | 24 | 0.037 | |
| positive regulation of dendritic cell dendrite assembly | GO:2000549 | 1 | 0.037 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.036 | |
| insemination | GO:0007320 | 6 | 0.036 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.036 | |
| interleukin 11 mediated signaling pathway | GO:0038154 | 2 | 0.036 | |
| t cell differentiation involved in immune response | GO:0002292 | 30 | 0.036 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.036 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.036 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.036 | |
| response to glucocorticoid | GO:0051384 | 20 | 0.036 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.036 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.035 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.035 | |
| renal system development | GO:0072001 | 225 | 0.035 | |
| peptide transport | GO:0015833 | 133 | 0.035 | |
| regulation of macrophage activation | GO:0043030 | 17 | 0.035 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.035 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.035 | |
| negative regulation of leukocyte apoptotic process | GO:2000107 | 31 | 0.034 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.034 | |
| gliogenesis | GO:0042063 | 141 | 0.034 | |
| urogenital system development | GO:0001655 | 261 | 0.034 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.034 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.034 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.034 | |
| response to radiation | GO:0009314 | 165 | 0.034 | |
| platelet activation | GO:0030168 | 40 | 0.034 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.034 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.033 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.033 | |
| regulation of immunoglobulin production | GO:0002637 | 42 | 0.033 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.033 | |
| cd4 positive alpha beta t cell proliferation | GO:0035739 | 2 | 0.033 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.033 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.033 | |
| gland development | GO:0048732 | 330 | 0.033 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.033 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.033 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.033 | |
| response to steroid hormone | GO:0048545 | 56 | 0.033 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.032 | |
| positive regulation of immunoglobulin production in mucosal tissue | GO:2000558 | 1 | 0.032 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.032 | |
| negative regulation of growth | GO:0045926 | 99 | 0.032 | |
| interleukin 8 production | GO:0032637 | 4 | 0.032 | |
| hexose transport | GO:0008645 | 56 | 0.032 | |
| stem cell development | GO:0048864 | 219 | 0.032 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.032 | |
| regulation of tube size | GO:0035150 | 57 | 0.032 | |
| pigmentation | GO:0043473 | 71 | 0.032 | |
| positive regulation vascular endothelial growth factor production | GO:0010575 | 10 | 0.032 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.031 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.031 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.031 | |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.031 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.031 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.031 | |
| immunoglobulin production | GO:0002377 | 73 | 0.031 | |
| t helper 2 cell cytokine production | GO:0035745 | 4 | 0.031 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.031 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 35 | 0.031 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.031 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.031 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.031 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.030 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.030 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.030 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.030 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.030 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.030 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.030 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.030 | |
| regulation of chemokine secretion | GO:0090196 | 4 | 0.029 | |
| kidney development | GO:0001822 | 213 | 0.029 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.029 | |
| gluconeogenesis | GO:0006094 | 39 | 0.029 | |
| antimicrobial peptide secretion | GO:0002776 | 1 | 0.029 | |
| regulation of protein transport | GO:0051223 | 163 | 0.029 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.029 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.029 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.029 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.029 | |
| activation of mapk activity | GO:0000187 | 59 | 0.029 | |
| response to interleukin 4 | GO:0070670 | 23 | 0.029 | |
| response to hydrogen peroxide | GO:0042542 | 32 | 0.029 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.029 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.028 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.028 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.028 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.028 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.028 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.028 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.028 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.028 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.028 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.028 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.028 | |
| response to pain | GO:0048265 | 26 | 0.027 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.027 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.027 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.027 | |
| regulation of macrophage chemotaxis | GO:0010758 | 8 | 0.027 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.027 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.026 | |
| lipid transport | GO:0006869 | 98 | 0.026 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.026 | |
| jnk cascade | GO:0007254 | 72 | 0.026 | |
| heart contraction | GO:0060047 | 93 | 0.026 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.026 | |
| natural killer cell chemotaxis | GO:0035747 | 1 | 0.026 | |
| positive regulation of muscle cell differentiation | GO:0051149 | 39 | 0.026 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.026 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.026 | |
| cation homeostasis | GO:0055080 | 212 | 0.026 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.026 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.026 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.026 | |
| rna interference | GO:0016246 | 2 | 0.026 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.025 | |
| tissue migration | GO:0090130 | 68 | 0.025 | |
| forebrain development | GO:0030900 | 302 | 0.025 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.025 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.025 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.025 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.025 | |
| glucose metabolic process | GO:0006006 | 92 | 0.025 | |
| b cell chemotaxis | GO:0035754 | 3 | 0.025 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.025 | |
| steroid metabolic process | GO:0008202 | 119 | 0.025 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.025 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.025 | |
| antibacterial peptide production | GO:0002778 | 2 | 0.025 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.025 | |
| regulation of glycoprotein biosynthetic process | GO:0010559 | 12 | 0.025 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.024 | |
| immunoglobulin production involved in immunoglobulin mediated immune response | GO:0002381 | 43 | 0.024 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.024 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.024 | |
| heart process | GO:0003015 | 94 | 0.024 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.024 | |
| interleukin 12 production | GO:0032615 | 32 | 0.024 | |
| defense response to gram negative bacterium | GO:0050829 | 28 | 0.024 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.024 | |
| organic acid transport | GO:0015849 | 101 | 0.024 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.024 | |
| regulation of cd4 positive alpha beta t cell proliferation | GO:2000561 | 2 | 0.024 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.024 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.024 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.023 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.023 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.023 | |
| organic anion transport | GO:0015711 | 137 | 0.023 | Rat |
| developmental maturation | GO:0021700 | 193 | 0.023 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.023 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.023 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.023 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.023 | |
| regulation of g protein coupled receptor protein signaling pathway | GO:0008277 | 37 | 0.023 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.023 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.023 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.023 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.023 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.023 | |
| ovulation | GO:0030728 | 15 | 0.023 | |
| response to amino acid | GO:0043200 | 37 | 0.023 | |
| negative regulation of response to oxidative stress | GO:1902883 | 10 | 0.022 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.022 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.022 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.022 | |
| protein kinase c activating g protein coupled receptor signaling pathway | GO:0007205 | 4 | 0.022 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.022 | |
| cellular response to peptide | GO:1901653 | 92 | 0.022 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.022 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.022 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.022 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.022 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.022 | |
